Dexamethasone

Dexamethasone has been studied in 68 papers since 2005: 5 trials and 10 observational studies in people, 36 in animals, 12 in cells, 2 reviews; 24 in the past year. The newest story, Nov 6, 2026: “A receptor helps keep muscle stem cells unspecialized in mice”.

Intervention

68 papers study it167 more mention it85 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 12% faster than aging research as a whole: 16 papers in the latest year counted

11 new papers in 30 daysSee all 234 papers on dexamethasone

At a glance

Dexamethasone shortens rat lifespan and increases senescence in rat cells across independent labs. One group reports lower mortality after hip-fracture surgery in a human trial, without clear physical-function improvement. One registered trial concerns aging; across all uses, 609 ended over a year ago without posted results or citing papers, and 28 have developer sponsorship; an author is affiliated with Osiris Therapeutics.

85 findings in 47 papers from 1997 to 2026, 6 of them since July 2026

The findings reach people, from one lab or study; independent labs found the same change in cells and mice. 40 independent labs in 19 countries; 1,950 trials, 586 with no results posted.

“There were 15 deaths (18.8%) in the dexamethasone group and 26 deaths (32.5%) in the placebo group (hazard ratio [HR] = 0.51, 95% confidence intervals [CI] = 0.27-0.96, P = 0.04).”
Efficacy of a single preoperative low-dose dexamethasone on 1-year mortality in geriatric femoral intertrochanteric fracture patients after internal fixation surgery: A randomized, placebo-controlled clinical trialChinese medical journal2025doi:10.1097/cm9.0000000000003731

4 of its findings point the other way.

Cells and mice: replicated by independent labs. Humans: a single group. Worms or flies: nothing yet.
  • 40 independent labs in 19 countries
  • 4 findings against
  • 1,950 trials, 586 with no results posted
  • Funders: National Institutes of Health and others
  • 1 of 84 findings with company ties
  • 71 of 1,950 trials sponsored by its developers
  • Human trial5
  • Humans10
  • Animals30
  • Model organisms5
  • Cells12
  • In silico2

Studies in people

2 studies gave dexamethasone to people and measured what changed.

What changedDesignPeopleSource

down: Decreases mortalityHR = 0.51, 95% CI = 0.27–0.96

no change: Has no effect on infection

no change: Has no effect on physical function

Randomized trial1 year160 people>60 yearsPatients diagnosed with ITF radiologicallyChinese medical journal, Jul 30, 2025

up: Improves first bed-chair transfer ability65.0% vs 48.8%, RR 1.46, 95% CI 1.02 to 2.11

down: Decreases in-hospital mortality1.3% vs 8.8%, RR 0.92, 95% CI 0.86 to 0.99, P = .07

no change: Has no effect on hyperglycemia

Randomized trialsingle dose160 peoplegeriatricOlder adults; undergoing internal fixation surgery for intertrochanteric fractureSurgery, Jul 21, 2023

What did studies of dexamethasone find?

66

Studies of dexamethasone measured 66 outcomes; the most studied are cellular senescence (6 studies), mortality (3) and inflammation (3).

Cellular senescence

upin human cells2upin mice1upin mouse cells1upin O. aries cells1+1

6 studies
  1. Dexamethasone induces cellular senescence in ovine chondrocytes.

    “DEX induced senescence without significant ROS or apoptosis”

    Cellsin ovine chondrocytesarticular cartilage1 μMn = 3

    Comparative phenotypic and molecular profiling of replicative and chemically-induced senescence in articular chondrocytes

    Cell death discovery

  2. Dexamethasone induces cellular senescence in dexamethasone-treated endothelial cells.

    “Specifically, DEX-induced EphB4 downregulation induced cellular senescence in ECs, and the resulting senescence-associated secretory phenotype (SASP) may further impair BMSC osteogenic differentiation.”

    Cellsin dexamethasone-treated endothelial cells

    Glucocorticoid impairs angiogenesis-dependent osteogenesis by downregulating EphB4 in endothelial cells

    Biochemical pharmacology

  3. Dexamethasone induces cellular senescence in human cells (associated with increased p21 (CDKN1A) expression, independently of p16 or p53).

    “DEX induced senescence in lung epithelial cells associated with increased p21 (CDKN1A) expression independently of p16 (CDKN2A) or p53 (TP53)”

    Cellsassociated with increased p21 (CDKN1A) expression, independently of p16 or p53lung epithelial cells

    Dexamethasone induces senescence of lung epithelial cells and augments TGF-β1-mediated production of the fibrosis mediator serpin E1 (plasminogen activator inhibitor-1)

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  4. Dexamethasone increases cellular senescence in mice (prenatal exposure).

    “increment of cellular senescence were found in metaphysis of long bone in mouse offspring after PDE”

    Animalsprenatal exposuremetaphysis of long bone1.2 mg/kg/daygestational days 12-14

    Cellular senescence mediates the detrimental effect of prenatal dexamethasone exposure on postnatal long bone growth in mouse offspring

    Stem cell research & therapy

  5. Dexamethasone induces cellular senescence in human cells.

    “Dex treatment of AECs produced nonreplicative and noninflammatory senescence.”

    Cellsamnion epithelial cells100 and 200 nM48 h

    Dexamethasone induces primary amnion epithelial cell senescence through telomere-P21 associated pathway†

    Biology of reproduction

  6. Dexamethasone increases cellular senescence in rat cells.

    “SA‐β‐gal staining indicated that DXM increased cell senescence.”

    Cellschondrocyte

    Effect of autophagy induced by dexamethasone on senescence in chondrocytes

    Molecular medicine reports

More on Cellular senescence

Mortality

downin humans1downin M. auratus1upin rats1HR 0.51

3 studies
  1. Dexamethasone decreases mortality in humans (HR = 0.51, 95% CI = 0.27–0.96).

    “Of the 41 deaths, 15 (18.8%, 15/80) occurred in the dexamethasone group, and 26 (32.5%, 26/80) occurred in the placebo group (hazard ratio [HR] = 0.51, 95% confidence interval [CI] = 0.27–0.96, P = 0.04) [Table ].”

    Human trial1 yearn = 160

    Efficacy of a single preoperative low-dose dexamethasone on 1-year mortality in geriatric femoral intertrochanteric fracture patients after internal fixation surgery: A randomized, placebo-controlled clinical trial

    Chinese medical journal

  2. Dexamethasone decreases mortality in humans (femoral intertrochanteric fracture patients after internal fixation surgery) (HR 0.51, 95% CI 0.27-0.96).

    “There were 15 deaths (18.8%) in the dexamethasone group and 26 deaths (32.5%) in the placebo group (hazard ratio [HR] = 0.51, 95% confidence intervals [CI] = 0.27-0.96, P = 0.04).”

    Human trialfemoral intertrochanteric fracture patients after internal fixation surgeryintravenous10 mgsingle dosen = 160

    Efficacy of a single preoperative low-dose dexamethasone on 1-year mortality in geriatric femoral intertrochanteric fracture patients after internal fixation surgery: A randomized, placebo-controlled clinical trial

    Chinese medical journal

  3. Dexamethasone decreases mortality in M. auratus (combined with heparin and CoVR-MV in SARS-CoV-2-infected aged hamsters).

    “the three-drug combination therapy resulted in a potent reduction of high mortality, body weight loss, viral load, lung pathology and cytokine storm”

    Animalscombined with heparin and CoVR-MV in SARS-CoV-2-infected aged hamsters

    A late-stage multi-dimensional intervention rescues lethal viral pneumonia in an aged hamster model

    Molecular biomedicine

  4. Dexamethasone increases mortality in rats.

    “DEX led to growth retardation, increased mortality, and severe kidney damage at 50 wk of age.”

    Animals

    Long-term effects of neonatal treatment with dexamethasone, L-carnitine, and combinations thereof in rats

    Pediatric research

Inflammation

downin human cells1no changein human cells1downin mice1

3 studies
  1. Dexamethasone decreases inflammation in human cells.

    “Dexamethasone reduced inflammation”

    Cellsfibroblast

    Unveiling the Biochemical Mechanisms of Aging and the Implications of Oxidative Stress on Cellular Senescence through Multi-Omics Analysis of Fibroblasts

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  2. Dexamethasone inhibits inflammation in mice (TSC1-null offspring; dexamethasone administered during pregnancy).

    “Dexamethasone administration during pregnancy decreased cyst formation by not only inhibiting the inflammatory response, but also interfering with the mTORC1 pathway.”

    AnimalsTSC1-null offspring; dexamethasone administered during pregnancykidney

    Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex-associated cystic kidney disease

    JCI insight

  3. Dexamethasone showed no clear effect on inflammation in human cells (dexamethasone-induced senescence).

    “Senescence was not associated with an increase in inflammatory mediators”

    Cellsdexamethasone-induced senescenceamnion epithelial cells100 and 200 nM48 h

    Dexamethasone induces primary amnion epithelial cell senescence through telomere-P21 associated pathway†

    Biology of reproduction

More on Inflammation

Lifespan

no changein mice1downin mice1downin rats1

3 studies
  1. Dexamethasone showed no clear effect on lifespan in MOG35-55-immunized NOD mice.

    “We found that dexamethasone and fingolimod did not affect the pattern of progression as well as survival.”

    Animalsin MOG35-55-immunized NOD micefemales

    The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis

    Neurobiology of disease

  2. Dexamethasone shortens lifespan in mice (prenatal exposure at E15.5).

    “Treated mice showed reduced LTD, impaired spatial learning, and a marked reduction in lifespan.”

    Animalsprenatal exposure at E15.5

    Prenatal corticosteroid exposure affects hippocampal plasticity and reduces lifespan

    Developmental neurobiology

  3. Dexamethasone shortens lifespan in rats (-25% (28.6 +/- 1.1 to 21.3 +/- 0.8 mo)).

    “neonatal treatment with dexamethasone significantly shortens the lifespan by 25% of male rats (28.6 +/- 1.1 to 21.3 +/- 0.8 mo)”

    Animalsmales

    Reduced life expectancy in rats after neonatal dexamethasone treatment

    Pediatric research

Infection

no changein humans2

2 studies
  1. Dexamethasone showed no clear effect on infection in humans.

    “No significant differences were found between the two groups (P >0.05) [Table ].”

    Human trial1 yearn = 160

    Efficacy of a single preoperative low-dose dexamethasone on 1-year mortality in geriatric femoral intertrochanteric fracture patients after internal fixation surgery: A randomized, placebo-controlled clinical trial

    Chinese medical journal

  2. Dexamethasone showed no clear effect on infection in humans (undergoing internal fixation surgery for intertrochanteric fracture).

    “No differences were found in the length of stay, infections, and hyperglycemia between the 2 groups.”

    Human trialundergoing internal fixation surgery for intertrochanteric fractureintravenous10 mgsingle dosen = 160

    The impact of preoperative single low-dose dexamethasone on in-hospital prognosis in geriatric intertrochanteric fracture patients: Analysis of secondary outcomes in a randomized controlled trial

    Surgery

More on Infection

Grip strength

downin mice2

2 studies
  1. Dexamethasone decreases grip strength in mice.

    “In terms of muscle strength reduction, the top three models were dexamethasone-induced, hindlimb suspension, and gene knockout models”

    Reviewdexamethasone-induced sarcopenia model, ranked first for muscle strength reduction among 11 models

    A Network Meta-Analysis of Sarcopenia Characteristic Indicators in Different Mouse Models of Muscular Dystrophy

    Research SquarePreprint

  2. Dexamethasone decreases grip strength in mice.

    “two sarcopenia animal models shared a comparable decrease in forelimb lean mass, muscle fibre size, grip strength and muscle contraction ability.”

    Animalsintraperitoneal injection20 mg/ kg body weight10 days

    Is dexamethasone-induced muscle atrophy an alternative model for naturally aged sarcopenia model?

    Journal of orthopaedic translation

Cell proliferation

no changein human cells1downin mice1

2 studies
  1. Dexamethasone showed no clear effect on cell proliferation in human cells.

    “Dex treatment did not induce AEC proliferation, cell cycle, influence viability, or morphology.”

    Cellsamnion epithelial cells100 and 200 nM48 h

    Dexamethasone induces primary amnion epithelial cell senescence through telomere-P21 associated pathway†

    Biology of reproduction

  2. Dexamethasone decreases cell proliferation in mice (prenatal exposure at E15.5).

    “Prenatal dexamethasone treatment decreased hippocampal cell proliferation in the dentate gyrus.”

    Animalsprenatal exposure at E15.5dentate gyrus

    Prenatal corticosteroid exposure affects hippocampal plasticity and reduces lifespan

    Developmental neurobiology

Collagen deposition

upin mice1

1 study
  1. Dexamethasone increases collagen deposition in mice (control and satellite cell-specific GR-deficient mice).

    “dexamethasone administration during the early inflammatory phase delayed regeneration, with persistent necrosis and increased collagen deposition.”

    Animalscontrol and satellite cell-specific GR-deficient miceskeletal muscleduring the early inflammatory phase

    A receptor helps keep muscle stem cells unspecialized in mice

    bioRxivPreprint

Muscle regeneration

downin mice1

1 study
  1. Dexamethasone impairs muscle regeneration in mice (control and satellite cell-specific GR-deficient mice).

    “dexamethasone administration during the early inflammatory phase delayed regeneration, with persistent necrosis and increased collagen deposition.”

    Animalscontrol and satellite cell-specific GR-deficient miceskeletal muscleduring the early inflammatory phase

    A receptor helps keep muscle stem cells unspecialized in mice

    bioRxivPreprint

IL-6

downin human cells1

1 study
  1. Dexamethasone decreases IL-6 in mechanically loaded MSC spheroids.

    “Dexamethasone suppressed inflammatory cytokine secretion and promoted M2-like macrophage polarization, whereas tocilizumab modulated immune responses without reducing cytokine production.”

    Cellsin mechanically loaded MSC spheroidsbone marrow mesenchymal stem cell

    Dynamic Compression Reveals Donor-Age-Associated Inflammaging in Human Mesenchymal Stromal Cell Spheroids

    ACS applied materials & interfaces

More on IL-6

Physical function

no changein humans1

1 study
  1. Dexamethasone showed no clear effect on physical function in humans.

    “There were no significant differences between the two groups (P >0.05).”

    Human trial1 year

    Efficacy of a single preoperative low-dose dexamethasone on 1-year mortality in geriatric femoral intertrochanteric fracture patients after internal fixation surgery: A randomized, placebo-controlled clinical trial

    Chinese medical journal

Cortisol

downin humans1−54% suppression

1 study
  1. Dexamethasone decreases cortisol in humans (54% suppression).

    “At baseline, plasma cortisol concentrations decreased significantly after DST in the entire group, a 54% suppression”

    Human trialBaseline dexamethasone suppression test in postmenopausal women with overweight and obesityplasmafemalesn = 60

    The Effects of Weight Loss and Aerobic Exercise on Cortisol and Cortisol Suppression in Postmenopausal Women with Overweight and Obesity

    Endocrine research

More on Cortisol

Hyperglycemia

no changein humans1

1 study
  1. Dexamethasone showed no clear effect on hyperglycemia in humans (undergoing internal fixation surgery for intertrochanteric fracture).

    “No differences were found in the length of stay, infections, and hyperglycemia between the 2 groups.”

    Human trialundergoing internal fixation surgery for intertrochanteric fractureintravenous10 mgsingle dosen = 160

    The impact of preoperative single low-dose dexamethasone on in-hospital prognosis in geriatric intertrochanteric fracture patients: Analysis of secondary outcomes in a randomized controlled trial

    Surgery

More on Hyperglycemia

In-hospital mortality

downin humans1RR 0.92

1 study
  1. Dexamethasone decreases in-hospital mortality in humans (undergoing internal fixation surgery for intertrochanteric fracture) (1.3% vs 8.8%, RR 0.92, 95% CI 0.86 to 0.99, P = .07).

    “One patient in the dexamethasone group and 7 patients in the placebo group died during hospitalization (1.3% [1/80] vs 8.8% [7/80], relative risk = 0.92, 95% confidence interval = 0.86 to 0.99; P = .07).”

    Human trialundergoing internal fixation surgery for intertrochanteric fractureintravenous10 mgsingle dosen = 160

    The impact of preoperative single low-dose dexamethasone on in-hospital prognosis in geriatric intertrochanteric fracture patients: Analysis of secondary outcomes in a randomized controlled trial

    Surgery

First bed-chair transfer ability

upin humans1RR 1.46

1 study
  1. Dexamethasone improves first bed-chair transfer ability in humans (undergoing internal fixation surgery for intertrochanteric fracture) (65.0% vs 48.8%, RR 1.46, 95% CI 1.02 to 2.11).

    “The dexamethasone group had a significantly higher rate of the first bed-chair transfer than the placebo group (65.0% [52/80] vs 48.8% [39/80], relative risk = 1.46, 95% confidence interval = 1.02 to 2.11; P = .038).”

    Human trialundergoing internal fixation surgery for intertrochanteric fractureintravenous10 mgsingle dosen = 160

    The impact of preoperative single low-dose dexamethasone on in-hospital prognosis in geriatric intertrochanteric fracture patients: Analysis of secondary outcomes in a randomized controlled trial

    Surgery

All 66

What is dexamethasone linked with?

3

Studies link dexamethasone with 3 measures: insulin resistance, early-onset colorectal cancer and weight gain.

Insulin resistance

upin humans1HR 7.04

1 study
  1. Dexamethasone is associated with insulin resistance in adult 21OHD patients without baseline IR (HR 7.04, 95% CI 1.81-27.34).

    “Importantly, dexamethasone use was independently associated with incident IR (HR 7.04, 95% CI 1.81-27.34; p = 0.005).”

    Humansin adult 21OHD patients without baseline IRn = 52

    Insulin Resistance Emerges Early After Glucocorticoid Treatment in Adult Patients With 21-Hydroxylase Deficiency

    Journal of diabetes

More on Insulin resistance

Early-onset colorectal cancer

upin humans1

1 study
  1. Dexamethasone is associated with early-onset colorectal cancer in humans (Compared with nonusers of systemic glucocorticoids) (EOCRC SIR 27, 95% CI 5.5–79).

    “dexamethasone (overall SIR, 2.9; 95% CI, 2.0-4.2; EOCRC SIR, 27; 95% CI, 5.5-79)”

    HumansCompared with nonusers of systemic glucocorticoids2005-2018

    Systemic Glucocorticoid Use and Risk of Colorectal Cancer, Especially Early-Onset Type: A Nationwide Cohort Study

    Journal of the National Comprehensive Cancer Network : JNCCN

More on Early-onset colorectal cancer

Weight gain

upin humans1OR 2.1

1 study
  1. Dexamethasone is associated with weight gain in humans (Mexican patients with breast cancer receiving adjuvant chemotherapy; multivariate analysis) (OR 2.1, 95% CI 1.04–4.23; p = .03).

    “dexamethasone dosage (OR = 2.1; 95% CI = 1.04-4.23; p = .03) and daily caloric intake”

    HumansMexican patients with breast cancer receiving adjuvant chemotherapy; multivariate analysisfemalesn = 200

    Body weight changes after adjuvant chemotherapy of patients with breast cancer: results of a Mexican cohort study

    European journal of cancer care

What acts on dexamethasone?

1

Studies name caloric restriction as acting on dexamethasone.

Caloric restriction

downin rats1

1 study
  1. Caloric restriction prevents dexamethasone in aging rats, in a region-specific manner.

    “food restriction reversed most of the dexamethasone-induced changes in the expression of genes involved in regulation of cholesterol homeostasis in aging rats”

    Animalsin aging rats, in a region-specific manner

    Food Restriction Counteracts Dexamethasone-Induced Downregulation of Genes Involved in Cholesterol Homeostasis in Rat Brain during Aging

    Brain sciences

More on Caloric restriction

Trial sponsors

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Dexamethasone improves retinal neurogenesis in aged mice undergoing reprogramming, lowers IL-6 in mechanically loaded human MSC spheroids, and reduces mortality and pneumonia with heparin and CoVR-MV in SARS-CoV-2-infected aged hamsters. Cells and mice each have single-group results, without opposing findings. Of 2,115 registered trials, 621 ended over a year ago without posted results; 46 have developer-company sponsorship.

  2. Summary written from the findings.

Latest

Dec 2025: 10Jan 2026: 7Feb 2026: 7Mar 2026: 7Apr 2026: 6May 2026: 3Jun 2026: 4Jul 2026: 7Aug 2026: 5Sep 2026: 8Oct 2026: 7Nov 2026: 576 papers in 12 months
bioRxiv

A receptor helps keep muscle stem cells unspecialized in mice

Mouse experiments found that steroid drugs’ effects on muscle repair were largely independent of the receptor in muscle stem cells.Mouse experiments found that steroid drugs’ effects on muscle repair were largely independent of the receptor in muscle stem cells.

Preprint: mouse studyMuscle
Advanced Functional Materials

Mitochondrial transfer restored bone structure in animals

In an osteoporosis animal model, mitochondria from treated stem cells promoted blood vessel formation and restored the structure of spongy bone.In an osteoporosis animal model, mitochondria from treated stem cells promoted blood vessel formation and restored the structure of spongy bone.

Experiments in animalsBones and joints

See all 234 papers on dexamethasone